Pfizer and BioNTech have started its enrolment of participants in South Africa for its phase 3 COVID-19 vaccine trials.
Pfizer & BioNTech phase 3 COVID-19 vaccine trials resume in SA
PUBLISHED: Thu, 01 Oct 2020 11:18:03 GMT
Pfizer and BioNTech have started its enrolment of participants in South Africa for its phase 3 COVID-19 vaccine trials.